Fluoroquinolone resistance of Staphylococcus epidermidis isolated from healthy conjunctiva and analysis of their mutations in quinolone-resistance determining region

doi:10.21203/rs.3.rs-52968/v2

Download PDF

Research

Fluoroquinolone resistance of Staphylococcus epidermidis isolated from healthy conjunctiva and analysis of their mutations in quinolone-resistance determining region

https://doi.org/10.21203/rs.3.rs-52968/v2

This work is licensed under a CC BY 4.0 License

Journal Publication

published 04 Nov, 2020

Read the published version in Antimicrobial Resistance & Infection Control →

You are reading this latest preprint version

Background: S. epidermidis is the most common pathogen in postoperative endophthalmitis and causes various infectious eye diseases. However, there is very little information on fluoroquinolone antibiotic resistance to S. epidermidis identified in conjunctival microbe and analysis of related genes. Here, the authors investigated the rate of resistance to fluoroquinolones of Staphylococcus epidermidis isolated from normal conjunctival microbes and mutations in the quinolone-resistance determining region (QRDR).

Methods: 377 eye samples from 187 patients who underwent intravitreal injection and cataract surgery were included. Specimens were taken from the bilateral lower conjunctival sacs using a cotton swab and cultured. The cultures were identified using MALDI-TOP MS and gyrA, gyrB, parC, and parE gene mutations of QRDR were confirmed by DNA extraction from resistant strains of S. epidermidis with a micro-dilution method using ciprofloxacin, levofloxacin, and moxifloxacin.

Results: The culture positive rate was 61.8% (231) for 374 eye samples. Of the 303 total strains cultured, S. epidermidis was the most common with 33.7% (102). Ten types of gene mutations were observed in the resistant S. epidermidis of 21 strains. One-point mutation was observed mainly in gyrA and parC, and a small number of mutations were observed in parE in the form of a double point mutations. When there were multiple point mutations in both gyrA and parC, the highest minimum inhibitory concentration (MIC) was observed.

Conclusions: The quinolone resistance rate of S. epidermidis increased in comparison with previous studies, and resistant S. epidermidis showed mostly QRDR mutations, which were mainly found in gyrA and parC, and showed strong resistance when mutated in both genes.

Infectious Diseases

Staphylococcus epidermidis

quinolone resistance

QRDR

mutation

conjunctiva

microbes

Postoperative endophthalmitis is a fatal complication that can lead to blindness, and it is essential to use appropriate antibiotics based on the causative microorganisms. The most common causative strain of postoperative endophthalmitis has been thought to be Staphylococcus epidermidis, a type of coagulase-negative staphylococci (CNS) [1–3]. Most of the isolates cultured from postoperative endophthalmitis come from conjunctival flora [4]. With this in mind, it is important to investigate the antibiotic susceptibility of S. epidermidis. Although S. epidermidis is the most common microorganism among conjunctival microbes, studies on the composition of the conjunctival microbes including S. epidermidis and their fluoroquinolone resistance are insufficient [5–7].

Fluoroquinolone, which is frequently used as a topical antibiotic agent in ophthalmology, primarily inhibits DNA gyrase (topoisomerase II) and topoisomerase lV, which are essential enzymes in bacteria [8–10]. This kind of antibiotics cover broad spectrum bacteria, including most aerobic gram-negative and gram-positive bacteria, and possess low toxicity and good ocular surface penetration characteristics [11,12]. In the 1990s, ciprofloxacin 0.3% and ofloxacin 0.3% were introduced, and were widely used for the treatment and prevention of ocular bacterial infection. Levofloxacin 0.5%, gatifloxacin 0.3%, and moxifloxacin 0.5% were introduced after 2000. Both gatifloxacin and moxifloxacin, which are 8-methoxyfluoroquinolones, interfere with bacterial DNA gyrase and topoisomerase IV, which are enzymes involved in DNA replication [13,14]. Fluoroquinolones are one of the most frequently used eyedrops in the prophylactic treatment of postoperative endophthalmitis. The incidence of in vitro resistance to these fluoroquinolones has been reported to be increasing [15–17]. Therefore, it is important to characterize the normal ocular bacterial flora and to determine antibiotic susceptibility patterns to select appropriate antibiotics for prophylaxis of postoperative endophthalmitis. There exist three research papers regarding fluoroquinolone resistance of conjunctival microbes from 1999, 2001, and 2009. The studies published in 2001 and 2009 reported that CNS resistance was increasing compared to previous reports [5–7]. Unfortunately, no studies on conjunctival normal flora have been reported for about 10 years, since 2009 [5–7].

In S. epidermidis, DNA gyrase and topoisomerase lV each have two subunits, GyrA and GyrB, and ParC and ParE, respectively. Most resistant bacteria show mutations in specific regions of these four subunits, the quinolone-resistance determining region (QRDR). The QRDR mutations of fluoroquinolone-resistant S. epidermidis cultured on the surface of the eyeball have not been studied [18,19]. It is important to characterize the normal bacterial flora in ocular surface and to determine the antibiotic susceptibility patterns to select appropriate antibiotics for prophylaxis of postoperative endophthalmitis.

Therefore, in this study, we investigated the composition of the normal conjunctival flora and the rate of resistance to the three fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) of S. epidermidis, considered to be the most common causative agent of postoperative endophthalmitis, and the gene mutation pattern of the QRDR of resistant S. epidermidis.

Research Subjects

A total of 187 patients (374 eye samples), from Kosin University Gospel Hospital between May 1, 2016 and September 31, 2017, were included. Of these, 120 (240 eyes) were scheduled for intravitreal injection and 67 (134 eyes) were scheduled for cataract surgery. Patients with the following conditions that were able to affect the conjunctival flora were excluded from the study: patients with a history of surgery, hospitalization, or use of systemic antibiotics within 3 months, patients who have used intraocular surgery or vitreous injection, glaucoma eye drops, or antimicrobial eye drops within 3 months.

Sample collection and storage

Samples were collected using a polyester tipped swab (23-400-122, Fisherbrand™, USA) from the lower conjunctival sac prior to the instillation of an anesthetic agent without the use of a prophylactic antimicrobial agent before the operation. Immediately after inoculation on a 5% blood agar plate, the cells were cultured for up to seven days in an incubator (Water-Jacketed CO2 Incubator, Forma Scientific, Inc., USA). When the bacteria grew, they were sorted based on the shape of the colony, and stored in Eppendorf tubes. Bacteria were harvested from 1–2 colonies in 1 mL of a mixture of glycerol and brucella broth (3:7) and stored in a -70°C cryogenic refrigerator.

Identification of bacteria

Frozen samples were thawed and inoculated on 5% blood agar plates using a 10 μL loop (SPL Life Sciences, Korea). Subsequently, the cells were subcultured once to identify the bacteria and conduct antimicrobial susceptibility tests. Identification of the bacteria was performed using Matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS, Bruker Daltonics GmbH, Germany).

Fluoroquinolone susceptibility test of S. epidermidis

The antimicrobial susceptibility test for the quinolone formulation was performed using a micro-dilution test using a liquid medium (tryptic soy broth: TSB) and a 96-well plate. The quinolone preparation was made by diluting ciprofloxacin 200 mg/100 mL (Ciprobay®, Bayer, Germany), Levofloxacin 750 mg (Cravit®, Jeilpharm, Korea), moxifloxacin hydrochloride 436.8 mg/250 mL (Avelox®, Bayer, Germany). The results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI M100 S26) standards, and the concentrations of the tolerance standards are shown in Table 1.

For ciprofloxacin and levofloxacin, the highest concentration was 32 μg/mL, the lowest concentration was 0.062 μg/mL; the highest concentration of moxifloxacin was 16 μg/mL, and the lowest concentration was 0.032 μg/mL. The bacterial dilution was incubated with tryptic soy agar (TSA) by thawing the stored frozen strain, and incubated for 24 hours. The resulting colonies were mixed well with sterile saline and adjusted to McFarland standard 0.5. The antibiotic solution was diluted by concentration, using cation adjusted Muller Hinton broth (CAMHB), and a strain solution diluted in 0.85% sterile physiological saline was divided into 96-well plates.

80 μL of liquid medium (CAMHB), 10 μL of diluted antibiotic, and 10 μL of strain solution were dispensed and cultured for 24 hours. Subsequently, 5 μL (10 mg/mL) of 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT, Sigma, USA) solution was added and observed to change color after two hours. The lowest inhibitory concentration was determined as the minimum inhibitory concentration (MIC, μg/mL). As a positive control group, medium and bacterial dilution were used; for a negative control, medium alone was used (Fig. 1).

Sequence analysis of polymerase chain reaction (PCR) and QRDR

In order to analyze the mutations of the QRDR sequence, 21 S. epidermidis strains with quinolone resistance confirmed were cultured in TSB for one day. In order to perform PCR, 0.5 μL of the TSB was taken. Next, 2 μL PCR primer (forward 1 μL, reverse 1 μL), 10 μL TOP real™ qPCR 2X Premix (Enzynomics, Korea), and 8 μL diethyl pyrocarbonate (DEPC) were mixed with water to perform PCR. The PCR primer for QRDR sequencing used the base sequence of S. epidermidis RP62A used by Yamada et al. [19]; 16S rRNA sequencing was also performed to confirm that it was an S. epidermidis strain. The sequence of the primer used is shown in Table 2. PCR was performed at 94˚C, 30 s, 55˚C, 30 s, 72˚C, and 1 min for 30 cycles, and the PCR product size was confirmed using 1.2% agarose gel electrophoresis (Fig. 2). PCR products were sequenced using DNA purification and an ABI PRISM 3730XL Analyzer (96 capillary type, Thermo Fisher Scientific, USA). For the 16S rRNA sequence, the bacteria were identified using the nucleotide Basic Local Alignment Search Tool (BLAST) of the National Center for Biotechnology Information (NCBI, supplementary table 2). For the QRDR sequence, SnapGene version 4.2 (GSL Biotech, Canada) and Genetyx version 6 (GENETYX CORP, Japan) were used to analyze the reference sequence (SE RP62A) and nucleotide homology.

Profile of isolated microorganisms

The positive rate of culture was 61.76%, or 231 out of 374 eye samples; 26.84%, or 62 of the 231 eye samples cultured two or more strains. There was 21.39%, or 40 out of 187 person cases in which more than one identical strains isolated from both eyes. The culture rates of gram-positive and -negative bacteria were 72.94% and 27.06%, respectively, and the composition is shown in Table 3 and 4. Among gram-positive bacteria, S. epidermidis was the most common isolate (102 eye samples, 33.66%), followed by Corynebacterium spp. (54 eye samples, 17.82%), of which 45 were Corynebacterium macginleyii. The third most cultured strain was CNS, excluding S. epidermidis (30 eye samples, 9.9%), followed by Enterococcus faecalis and S. aureus (10 eye samples, 3.3%).

Among gram-negative bacteria, Ochrobactrum spp. were the most common isolate (33 eye samples, 10.89%), and Ochrobactrum intermedium was cultured in 23 of 33 eye samples. The second most cultured strain was Pseudomonas spp. (11 eye samples, 3.63%), followed by Achromobacter spp. (7 eye samples, 2.31%), and Brevundimonas spp. (7 eye samples, 2.31%).

S. epidermidis fluoroquinolone susceptibility test

Of the 102 S. epidermidis strains, antibiotic susceptibility tests were performed on 82 strains owing to the loss of 20 strains due to storage problems, and the results are shown in supplementary table 1. Table 4 shows the ciprofloxacin, levofloxacin, and moxifloxacin susceptibility results for 21 bacteria that showed resistance to the fluoroquinolones.

QRDR gene mutation pattern

A total of 10 types of QRDR gene mutation patterns were observed (Table 5). Point mutations were observed mainly in gyrA and parC, and the most common ones were Ser84Phe in GyrA and Ser80Tyr in ParC. A small number of mutations were also observed in parE, with double point mutations mainly occurring in Lys402Arg, Asn404Ile, Lys403Thr, Asn404Asp, and Lys402Arg. No strain showing gyrB mutation was found, and in one strain, no mutation was observed in the QRDR (type 10).

As a result of cultivating samples collected from the lower conjunctival sac, most (72.94%) of the normal conjunctival flora comprised gram-positive bacteria. The most isolated S. epidermidis with a single strain was similar to the previous domestic report [5,6]. However, some differences from previous domestic and foreign studies were observed in the composition of normal flora. The first difference was that the cultivation rate of S. epidermidis among gram-positive bacteria was significantly reduced. In this study, the culture rate of S. epidermidis was 33.7% of the total cultured strains, which is a significantly lower culture rate compared to 60.6% in 2009 domestic reports [7] and 56.4% in 2013 Midwest reports [20]. The cause of this phenomenon is probably related to the increased use of topical antibiotics, that is, the use of fluoroquinolone as an ophthalmic antibiotic. The most commonly prescribed topical antibiotic after cataract surgery reported by the Survey of Korean Society of Cataract and Refractive Surgery was fluoroquinolone, which increased from 78% in 2007 to 85% in 2012. Among them, the frequency of prescriptions for moxifloxacin, a third-generation fluoroquinolone, rose sharply from 11% in 2007 to 44% in 2012 [21,22]. The second difference was that the culture rate of Corynebacterium spp. among the gram-positive bacteria increased significantly. In previous domestic reports [5–7], Corynebacterium spp. accounted for less than 10% of all strains of Gram-positive bacteria, but in this study, it was observed with a high culture rate of 17.8% compared to 3.3% of Staphylococcus aureus culture. (Table 3)

Among the gram-negative bacteria, there were notable differences compared to previous studies. In previous domestic studies [5–7], Pseudomonas spp. was observed at a high rate, but in this study, Ochrobactrum spp. was cultured at the highest rate. Ochrobactrum intermedium was observed in 23 of 33 eyes with Ochrobactrum spp, and this strain was not well identified by previous biochemical research methods, but is known to be identified by MALDI-TOF mass spectrometry, a commonly-used identification method [27]. In other words, in previous domestic studies [5–7], it was thought that it was difficult to identify this strain because bacteria were mainly identified using biochemical methods. Ochrobactrum intermedium has been reported to cause endophthalmitis in relation to metal ocular foreign bodies [31], and infections other than the eye are rare, so there have not been many studies [30]. It is noteworthy that, despite the strains that were not mentioned at all as constitutive gram-negative bacteria in the previous conjunctival normal flora study in Korea, they were the third most cultivated in this study after S. epidermidis and C. macginleyi. There was a case report where this bacteria was specifically identified as a causative agent of intraocular salt; we believe that it should be studied with more interest in the future because it was resistant to both the traditional vitreous injection antibiotics vancomycin and ceftazidime.

The most isolated strains in normal conjunctiva are CNS, most of which are S. epidermidis [7,32]. There were three reports of CNS antibiotic resistance in normal conjunctival flora in Korea in 1999, 2001, and 2009. Since the first published study, the other two studies reported that CNS quinolone resistance had increased compared to previous reports [5,7]. Since this study investigated the quinolone resistance of S. epidermidis, it is difficult to compare 1:1 with previous CNS resistance reports; however, most of the CNS identified in the conjunctiva are S. epidermidis, so a rough comparison is possible. CNS susceptibility to ciprofloxacin was reported to be gradually decreased to 92.3% in 1999, 80.5% in 2001, and 69.2% in 2009, and 67.1% in this study (not statistically different from 2009). CNS susceptibility to levofloxacin was reported only in the 2009 study, and 78.7% was found to have significantly decreased susceptibility, compared to 67.1% in this study. In particular, in the 2009 report, levofloxacin sensitivity was reported at 50% for ciprofloxacin-resistant CNS strains; however, levofloxacin was also not effective for all ciprofloxacin-resistant CNS strains. The CNS susceptibility to moxifloxacin was reported only in 2009, at a rate of 89.7%, which is a significantly decreased sensitivity compared to the 74.4% in this study. Of the 20 strains that were resistant to levofloxacin, only one strain (5%) was susceptible to moxifloxacin, six strains (30%) were moderately resistant, and the remaining thirteen strains (65%) were resistant. A 2009 study reported that about 50% of levofloxacin-resistant strains showed susceptibility to 4th-generation quinolone. Based on this, it is believed that the strains showing resistance to all three quinolones increased when interpreting the results of this study. It is known that the prescription dose and resistance to antibiotics are closely related [33,34]. As mentioned above, it is estimated that the increase in use of high-generation quinolone antibiotics may lead to an increase in S. epidermidis, which is resistant to all three quinolones.

In this study, QRDR mutation was observed in 20 of the 21 strains of quinolone-resistant S. epidermidis. The QRDR mutation pattern showed similar results compared to previous reports [18,19,35]. Mostly, there were mutations in gyrA and parC, and in 80 and 88 parC of gyrA, 80 and 84 of parC are found in this study, which is similar to the previous report. As compared with quinolone-resistant S. epidermidis identified in the skin, the results of this study showed a difference in the amino acid types of mutations, but the gyrA and parC mutation locations and overall patterns were similarly observed.[18] In previous S. aureus studies, mutations due to resistance were not observed in gyrB, but in the form of Ser84Leu and Glu88Lys mutations in gyrA, the position and pattern of gyrA mutations in resistant S. epidermidis are similar. The grlA and grlB mutations of S. aureus corresponding to parC and parE were similar to those of this study [15,19].

When the number of QRDR mutations and the MIC value were correlated, the number of mutations and the MIC value tended to be proportional. However, in the case of parE, the number of mutations did not seem to affect the magnitude of tolerance as much as gyrA and parC (Table 6). The strains that showed the strongest resistance were those that showed multiple mutations in both gyrA and parC, and strains exhibiting this mutation are known to be rare in S. epidermidis [8,9]. However, in S. aureus, there are reports that more than 50% of strains showed mutations in both gyrA and grlA [15].

Lastly, in one strain, no mutation was observed in QRDR, but this strain was thought to exhibit quinolone resistance by mechanisms other than QRDR mutation [36], such as draining the drug out or having a resistance gene in the plasmid. In particular, this strain was sensitive to ciprofloxacin and levofloxacin of the lower generation, but showed resistance only to the highest generation moxifloxacin. Moxifloxacin is an important antibiotic in relation to surgical and severe infections in the ophthalmic area, so it would be meaningful to further study this strain in the future.

The limitation of this study was that only aerobic bacteria cultured in a nutrient medium were included in the study as a limitation of the method for culturing the bacteria. In addition, all breakpoints used here were based on systemic breakpoints provided by CLSI or derived from the method suggested by CLSI. However, the breakpoint for topical therapy has not been established so far. The concentration of antibiotic eye drops that are usually instilled in the eye is much higher than the CLSI resistance reference concentration. For this reason, it is important to investigate the resistance rate of one strain, but it is also necessary to study the changes in the superiority of the strains caused by the antibiotic drop and animal experiments later.

Studies on the normal conjunctival flora can play a very important role in understanding various ocular infectious diseases. In addition, the resistance rate and resistance gene analysis of the strain constituting the normal conjunctival flora can also provide important guidelines and data on how to use and develop antibiotics in the future. The changes in the bacterial flora and increased S. epidermidis resistance to 4th-generation quinolone in this study suggest that ophthalmologists prescribe a lot of higher-generation quinolone.

In conclusion, this study showed the composition of normal conjunctival flora, the change in quinolone resistance rate of S. epidermidis, and the resistance gene mutation pattern. The ratio of Corynebacterium spp. among the gram-positive bacteria of the quinolone-resistant strain increased in the normal conjunctival flora, and among the gram-negative bacteria, Ochrobactrum spp., which was not mentioned in the previous domestic report, were cultured the most. The quinolone resistance of S. epidermidis increased compared to the previous domestic studies, and the strains resistant to all quinolones increased. Lastly, quinolone-resistant S. epidermidis showed mostly QRDR mutations, mainly in gyrA and parC, and showed the strongest resistance when both genes were mutated. These results indicate that antimicrobial stewardship is required even more in the ophthalmic area when using topical antibiotics eye drops.

Abbreviations

CNS: Coagulase-negative staphylococci; QRDR: Quinolone-resistance determining region; MALDI-TOF MS: Matrix assisted laser desorption/ionization time-of-flight mass spectrometry; TSB: tryptic soy broth; Clinical and Laboratory Standards Institute: CLSI; TSA: tryptic soy agar; CAMHB: Cation adjusted Muller Hinton broth; MTT: 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide; MIC: minimum inhibitory concentration; PCR: polymerase chain reaction; DEPC: diethyl pyrocarbonate; NCBI: National Center for Biotechnology Information

Acknowledgements

We are grateful for the useful comments and suggestions from anonymous referees.

Authors’ contributions

Kang, JY and Lee, SJ participated in the design of the study and performed the statistical analysis; Park, I and Lee, W participated in the design of the study and helped to draft the manuscript; Noh KM, Jeong, BH and Kim, HW carried out data collection and review the manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its supplementary information files.

Ethics approval and consent to participate

Institutional review board approval was obtained from Kosin University Gospel hospital (2017-11-045-003).

Consent for publication

Not applicable.

Competing interests

The authors do not have any financial competing interests.

Benz MS, Scott IU, Flynn HW, Unonius N, Miller D, Flynn Jr HW, et al. Endophthalmitis isolates and antibiotic sensitivities: A 6-year review of culture-proven cases. Am J Ophthalmol [Internet]. Elsevier Inc.; 2004;137:38–42. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0002939403008961
HAN DP, Wisniewski SR, Wilson LA, Barza M, VINE AK, Doft BH, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol [Internet]. Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, USA.: Elsevier Inc.; 1996;122:1–17. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0002939414719592
Pijl BJ, Theelen T, Tilanus MADD, Rentenaar R, Crama N. Acute Endophthalmitis After Cataract Surgery: 250 Consecutive Cases Treated at a Tertiary Referral Center in the Netherlands. Am J Ophthalmol [Internet]. Elsevier Inc.; 2010;149:482-487.e2. Available from: http://www.nature.com/doifinder/10.1038/eye.2017.85
Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The Source of Coagulase-Negative Staphylococci in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol (Chicago, Ill 1960) [Internet]. 1997;115:357. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.1997.01100150359008
Park H, Yi G, Moon N. Bacteriologic Study on Normal Conjunctival Flora and Change of Antibiotic Susceptability. J Korean Ophthalmol Soc. 2001;42:817–24.
Yi T, Choi S. The Trend of Species and Microbial Susceptibility of Bacteria Isolated from the Anophthalmic Socket and Fellow Normal Conjunctiva. J Korean Ophthalmol Soc. 1999;40:2074–86.
Park SH, Lim J-A, Choi J-S, Kim K-A, Joo C-K. The Resistance Patterns of Normal Ocular Bacterial Flora to 4 Fluoroquinolone Antibiotics. Cornea [Internet]. 2009;28:68–72. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003226-200901000-00016
Dubin DT, Fitzgibbon JE, Nahvi MD, John JF. Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother. 1999;43:1631–7.
Li Z, Deguchi T, Yasuda M, Kawamura T, Kanematsu E, Nishino Y, et al. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother [Internet]. 1998;42:3293–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9835531
Sreedharan S, Peterson LR, Fisher LM. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: Role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 1991;35:2151–4.
Healy DP, Holland EJ, Nordlund ML, Dunn S, Chow C, Lindstrom RL, et al. Concentrations of Levofloxacin, Ofloxacin, and Ciprofloxacin in Human Corneal Stromal Tissue and Aqueous Humor After Topical Administration. Cornea [Internet]. 2004;23:255–63. Available from: http://journals.lww.com/00003226-200404000-00007
Diamond JP, White L, Leeming JP, Hoh HB, Easty DL. Topical 0 3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: A new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol. 1995;79:606–9.
Blondeau JM. Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol [Internet]. Elsevier Inc; 2004;49 Suppl 2:1–6. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=15028482&retmode=ref&cmd=prlinks
Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol [Internet]. Elsevier Inc; 2004;49:S79–83. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0039625704000050
Iihara H, Suzuki T, Kawamura Y, Ohkusu K, Inoue Y, Zhang W, et al. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn Microbiol Infect Dis. 2006;56:297–303.
Miyanaga M, Nejima R, Miyai T, Miyata K, Ohashi Y, Inoue Y, et al. Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones. J Cataract Refract Surg [Internet]. ASCRS and ESCRS; 2009;35:1970–8. Available from: http://dx.doi.org/10.1016/j.jcrs.2009.05.049
Kim SJ, Toma HS. Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology [Internet]. 2011;118:1358–63. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0161642010013072
Betanzos-Cabrera G, Juárez-Verdayes MA, González-González G, Cancino-Díaz ME, Cancino-Díaz JC. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyra and parc genes of staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res. 2009;42:43–8.
Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br J Ophthalmol. 2008;92:848–51.
Hsu HY, Lind JT, Tseng L, Miller D. Ocular flora and their antibiotic resistance patterns in the midwest: A prospective study of patients undergoing cataract surgery. Am J Ophthalmol [Internet]. Elsevier; 2013;155:36-44.e2. Available from: http://dx.doi.org/10.1016/j.ajo.2012.06.024
Paik HJ, Song HJ, Shyn KH. 2007 Survey for KSCRS Members - Current Trends in Cataract Surgery in Korea -. J Korean Ophthalmol Soc [Internet]. 2009;50:1624. Available from: https://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2009.50.11.1624
Wi JM, Moon HS, Kim KH, Shyn KH. 2012 Survey of KSCRS and KOS Member: Current Trends in Cataract Surgery in Korea. J Korean Ophthalmol Soc. 2015;56:1181.
Joussen AM, Funke G, Joussen F, Herbertz G. Corynebacterium macginleyi: A conjunctiva specific pathogen. Br J Ophthalmol. 2000;84:1420–2.
Riegel P, Ruimy R, de Briel D, Prévost G, Jehl F, Christen R, et al. Genomic diversity and phylogenetic relationships among lipid-requiring diphtheroids from humans and characterization of Corynebacterium macginleyi sp. nov. Int J Syst Bacteriol [Internet]. 1995;45:128–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7857793
Von Graevenitz A, Schumacher U, Bernauer W. The corynebacterial flora of the normal human conjunctiva is lipophilic. Curr Microbiol. 2001;42:372–4.
Suzuki T, Iihara H, Uno T, Hara Y, Ohkusu K, Hata H, et al. Suture-related keratitis caused by Corynebacterium macginleyi. J Clin Microbiol. 2007;45:3833–6.
Alsuwaidi AR, Wiebe D, Burdz T, Ng B, Reimer A, Singh C, et al. Corynebacterium macginleyi conjunctivitis in Canada. J. Clin. Microbiol. 2010. p. 3788–90.
Ruoff KL, Toutain-Kidd CM, Srinivasan M, Lalitha P, Acharya NR, Zegans ME, et al. Corynebacterium macginleyi isolated from a corneal ulcer. Infect Dis Rep. 2010;2:7–8.
Ferrer C, Ruiz-Moreno JM, Rodríguez A, Montero J, Alió JL. Postoperative Corynebacterium macginleyi endophthalmitis. J Cataract Refract Surg. 2004;30:2441–4.
Bharucha T, Sharma D, Sharma H, Kandil H, Collier S. Ochromobactrum intermedium: an emerging opportunistic pathogen—case of recurrent bacteraemia associated with infective endocarditis in a haemodialysis patient. New Microbes New Infect [Internet]. The Authors; 2017;15:14–5. Available from: http://dx.doi.org/10.1016/j.nmni.2016.09.016
Jacobs DJ, Grube TJ, Flynn HW, Greven CM, Pathengay A, Miller D, et al. Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body. Clin Ophthalmol. 2013;7:1727–30.
Suto C, Morinaga M, Yagi T, Tsuji C, Toshida H. Conjunctival sac bacterial flora isolated prior to cataract surgery. Infect Drug Resist. 2012;5:37–41.
Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, Koh TH, et al. Surveillance and correlation of antibiotic prescription and resistance of gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother. 2010;54:1173–8.
YA K, Park Y, Youk T, Lee S, Sohn Y. Research on the use of antibacterial agents in Korea and the resistance of major pathogens to antibacterial agents. 2016.
Jena S, Panda S, Nayak KC, Singh D V. Identification of major sequence types among multidrug-resistant Staphylococcus epidermidis strains isolated from infected eyes and healthy conjunctiva. Front Microbiol. 2017;8:1–12.
Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis [Internet]. 2005;41 Suppl 2:S120-6. Available from: http://cid.oxfordjournals.org/content/41/Supplement_2/S120.long

Table 1. Clinical and Laboratory Standards Institute Performance Standards for dilution antimicrobial susceptibility tests

Antimicrobial agent	MIC (μg/mL) Interpretive Standard
Antimicrobial agent	Susceptible	Intermediate	Resistant
Ciprofloxacin	≤ 1	2	≥ 4
Levofloxacin	≤ 1	2	≥ 4
Moxifloxacin	≤ 0.5	1	≥ 2

*MIC: minimal inhibitory concentration

Table 2. Primers used in the study. Nucleotide positions are indicated according to GenBank sequence number NC 002976 (Staphylococcus epidermidis RP62A).

Target gene	Primer sequence (5’ to 3’)	Product size (bp)
gyrA (FOR)	ATGCGTGAATCATTCTTAGACTATGC	284
gyrA (REV)	GAGCCAAAGTTACCTTGACC	284
gyrB (FOR)	CAGCATTAGACGTTTCAAG	251
gyrB (REV)	CCAATACCCGTACCAAATGC	251
parC (FOR)	TCGCAATGTATTCAAGTGGG	197
parC (REV)	ATCGTTATCGATACTACCATT	197
parE (FOR)	AAGCTCAACAAGCACGCGAGGCTG	324
parE (REV)	TTAAAGTCAGTACCAACACCAGCAC	324

Table 3. Profile of microorganisms isolated from lower conjunctival sac of eyes undergoing cataract surgery and intravitreal injection.

Gram + bacteria ( n= 221 )	Number of isolates (%)	Gram - bacteria ( n = 82 )	Number of isolates (%)
Staphylococcus epidermidis	102 (33.7%)	Ochrobactrum spp.	33 (10.9%)
Corynebacterium spp.	54 (17.8%)	Pseudomonas spp.	11 (3.6%)
Other CNS	30 (9.9%)	Achromobacter spp.	7 (2.3%)
Enterococcus faecalis	10 (3.3%)	Brevundimonas spp.	7 (2.3%)
Staphylococcus aureus	10 (3.3%)	Enterobacter aerogenes	4 (1.3%)
Micrococcus luteus	6 (2%)	Roseomonas gilardii	4 (1.3%)
Propionibacterium avidum	4 (1.3%)	Bordetella hinzii	3 (1%)
Kocuria spp.	3 (1%)	Acinetobacter baylyi	2 (0.7%)
Bacillus pumilus	1 (0.3%)	Delftia acidovorans	2 (0.7%)
Dermabacter hominis	1 (0.3%)	Proteus mirabilis	2 (0.7%)
		Sphingomonas paucimobilis	2 (0.7%)
		Stenotrophomonas maltophilia	2 (0.7%)
		Cupriavidus pauculus	1 (0.3%)
		Moraxella spp.	1 (0.3%)
		Morganella morganii	1 (0.3%)

Table 4. Susceptibility rates of Staphylococcus epidermidis (n=82) to 3 fluoroquinolone antibiotics

	Ciprofloxacin, n(%)	Levofloxacin, n(%)	Moxifloxacin, n(%)
Susceptible	55 (67.1%)	55 (67.1%)	61 (74.4%)
Intermediate	8 (9.8%)	7 (8.5%)	7 (8.5%)
Resistant	19 (23.2%)	20 (24.4%)	14 (17.1%)

Table 5. Mutations in the quinolone resistance determining region (QRDR) of gyrA, gyrB, parC and parE in 21 strains of Staphylococcus epidermidis.

Mutation type	No. of isolates	Mutation
Mutation type	No. of isolates	gyrA	gyrB	parC	parE
1	7	Ser84Phe	-	Ser80Tyr	-
2	4	Ser84Phe	-	Ser80Phe	-
3	3	Ser84Phe	-	Ser80Phe+Asp84Val	-
4	1	Ser84Tyr	-	Ser80Ile	-
5	1	Ser84Tyr	-	Ser80Ile	Lys402Arg+Asn404Ile
6	1	Ser84Phe	-	Ser80Phe+Asp84Val	Lys403Thr+Asn404Asp
7	1	Ser84Phe	-	Ser80Phe+Asp84Val	Lys402Arg+Lys403Arg
8	1	Ser84Tyr+Glu88Lys	-	Ser80Phe+Asp84Tyr	-
9	1	Ser84Phe	-	Ser80Phe	Asp434Val
10	1	-	-	-	-

Table 6. Mutations in the quinolone resistance determining region (QRDR) and minimal inhibitory concentrations (MIC, μg/mL)

Mutation type	No. of isolates	Mutation				MIC (μg/mL)
Mutation type	No. of isolates	gyrA	gyrB	parC	parE	CFX(≥4)	LFX(≥4)	MFX(≥2)
1	7	Ser84Phe	-	Ser80Tyr	-	4	4	1
		Ser84Phe	-	Ser80Tyr	-	4	4	1
		Ser84Phe	-	Ser80Tyr	-	8	8	2
		Ser84Phe	-	Ser80Tyr	-	4	8	1
		Ser84Phe	-	Ser80Tyr	-	2	4	1
		Ser84Phe	-	Ser80Tyr	-	4	4	1
		Ser84Phe	-	Ser80Tyr	-	4	4	1
2	4	Ser84Phe	-	Ser80Phe	-	8	8	2
		Ser84Phe	-	Ser80Phe	-	16	8	1
		Ser84Phe	-	Ser80Phe	-	8	8	2
		Ser84Phe	-	Ser80Phe	-	8	8	2
3	3	Ser84Phe	-	Ser80Phe+Asp84Val	-	16	8	2
		Ser84Phe	-	Ser80Phe+Asp84Val	-	32	8	2
		Ser84Phe	-	Ser80Phe+Asp84Val	-	32	8	2
4	1	Ser84Tyr	-	Ser80Ile	-	32	8	2
5	1	Ser84Tyr	-	Ser80Ile	Lys402Arg+Asn404Ile	16	8	2
6	1	Ser84Phe	-	Ser80Phe+Asp84Val	Lys403Thr+Asn404Asp	16	8	2
7	1	Ser84Phe	-	Ser80Phe+Asp84Val	Lys402Arg+Lys403Arg	32	8	2
8	1	Ser84Tyr+Glu88Lys	-	Ser80Phe+Asp84Tyr	-	64	64	32
9	1	Ser84Phe	-	Ser80Phe	Asp434Val	8	8	2
10	1	-	-	-	-	2	2	8

CFX: ciprofloxacin, LFX: levofloxacin, MFX: moxifloxacin

Supplementary files were not provided with this version of the manuscript.

Download PDF

Journal Publication

published 04 Nov, 2020

Read the published version in Antimicrobial Resistance & Infection Control →

Reviewers invited by journal
26 Oct, 2020
Reviewer #1 agreed at journal
26 Oct, 2020
Reviewer #2 agreed at journal
26 Oct, 2020
Review #2 received at journal
26 Oct, 2020
Review #1 received at journal
26 Oct, 2020
Editorial decision: Accept
26 Oct, 2020
Editor assigned by journal
24 Oct, 2020
Submission checks completed at journal
23 Oct, 2020
Editor invited by journal
23 Oct, 2020

You are reading this latest preprint version

Fluoroquinolone resistance of Staphylococcus epidermidis isolated from healthy conjunctiva and analysis of their mutations in quinolone-resistance determining region

Status:

Journal Publication

Version 2

Abstract

Figures

Background

Methods

Results

Discussion

Conclusions

Declarations

References

Tables

Supplementary Information

Status:

Journal Publication

Version 2